These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 7716926)

  • 1. [The effect of fetal calf serum on the anti-HIV properties of miramistin].
    Krivorutchenko IuL; Krivoshein IuS; Andronovskaia IB; Nosik DN; Kalnina LB; Petrova MS
    Vopr Virusol; 1994; 39(6):281-3. PubMed ID: 7716926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of the anti-HIV activity of miramistin].
    Krivorutchenko IuL; KrivosheinIuS ; Marennikova SS; Stepanova LG; Nosik DN; Kalnina LB; Rud'ko AP
    Vopr Virusol; 1994; 39(6):267-9. PubMed ID: 7716921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dose-dependent inactivation of extracellular human immunodeficiency virus by miramistin].
    Krivorutchenko IuL
    Vopr Virusol; 1998; 43(3):122-4. PubMed ID: 9702810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiseptic myramistin possesses the strong anti-HIV properties.
    Kryvorutchenko IuL; Kryvosheïn IuS; Andronovs'ka IB; Marennykova SS; Stepanova LH; Nosyk DN; Kalnina LB; Rud'ko AP
    Mikrobiol Z; 1996; 58(5):90-2. PubMed ID: 8993062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prospects of using miramistin for individual prevention of sexual HIV transmission].
    Krivorutchenko IuL; Andronovskaia IB
    Lik Sprava; 2013 Mar; (2):117-23. PubMed ID: 24605621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibacterial activity and clinical effectiveness of the new antiseptic miramistin].
    Vasil'eva TV; Raskidaĭlo AS; Arutcheva AA; Okropiridze GG; Petrakov AA; Urazgil'deev ZI; Kovalenko TM
    Antibiot Khimioter; 1993; 38(8-9):61-3. PubMed ID: 8037581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The research of antimicrobial efficacy of antiseptics decamethoxin, miramistin and their effect on nuclear DNA fragmentation and epithelial cell cycle.
    Nazarchuk OA; Chereshniuk IL; Nazarchuk HH
    Wiad Lek; 2019; 72(3):374-380. PubMed ID: 31050983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-HIV-1 activity of sulfated amphotericin B in vitro.
    Otake T; Miyano K; Mori H; Morimoto M; Ueba N; Kunita N; Nakashima H; Kurimura T
    Antiviral Res; 1991 Oct; 16(3):243-55. PubMed ID: 1805684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiseptic Miramistin: a review of its comparative in vitro and clinical activity.
    Osmanov A; Farooq Z; Richardson MD; Denning DW
    FEMS Microbiol Rev; 2020 Jul; 44(4):399-417. PubMed ID: 32386213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo efficacy of miramistin against drug-resistant fungi.
    Osmanov A; Wise A; Denning DW
    J Med Microbiol; 2019 Jul; 68(7):1047-1052. PubMed ID: 31169488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of serotonin and melanin on in vitro HIV-1 infection.
    Sidibe S; Saal F; Rhodes-Feuillette A; Lagaye S; Pelicano L; Canivet M; Peries J; Dianoux L
    J Biol Regul Homeost Agents; 1996; 10(1):19-24. PubMed ID: 9049777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of AIDS virus replication by acemannan in vitro.
    Kahlon JB; Kemp MC; Carpenter RH; McAnalley BH; McDaniel HR; Shannon WM
    Mol Biother; 1991 Sep; 3(3):127-35. PubMed ID: 1768365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of human serum on the in vitro anti-HIV-1 activity of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) derivatives as related to their lipophilicity and serum protein binding.
    Baba M; Yuasa S; Niwa T; Yamamoto M; Yabuuchi S; Takashima H; Ubasawa M; Tanaka H; Miyasaka T; Walker RT
    Biochem Pharmacol; 1993 Jun; 45(12):2507-12. PubMed ID: 8328988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of tat-mediated HIV-1-LTR transactivation and virus replication by sulfhydryl compounds with chelating properties.
    Demirhan I; Chandra A; Sarin PS; Hasselmayer O; Hofmann D; Chandra P
    Anticancer Res; 2000; 20(4):2513-7. PubMed ID: 10953320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiamine disulfide as a potent inhibitor of human immunodeficiency virus (type-1) production.
    Shoji S; Furuishi K; Misumi S; Miyazaki T; Kino M; Yamataka K
    Biochem Biophys Res Commun; 1994 Nov; 205(1):967-75. PubMed ID: 7999140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of HIV-1 replication in H9 cells by nystatin-A compared with other antiviral agents.
    Selvam MP; Blay RA; Geyer S; Buck SM; Pollock L; Mayner RE; Epstein JS
    AIDS Res Hum Retroviruses; 1993 May; 9(5):475-81. PubMed ID: 7686387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of detergents on pathogenicity plasmids of escherichias.
    Krivoshein YuS ; Achkasova YuN ; Bryzgunova NI; Sarachan TA; Myshak VI; Miloserdova NA
    J Hyg Epidemiol Microbiol Immunol; 1988; 32(3):345-52. PubMed ID: 3058793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of HIV-1 replication by propolis and its immunoregulatory effect.
    Harish Z; Rubinstein A; Golodner M; Elmaliah M; Mizrachi Y
    Drugs Exp Clin Res; 1997; 23(2):89-96. PubMed ID: 9309384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The anti-HIV activity of beta-glycyrrhizic acid].
    Pliasunova OA; Egoricheva IN; Fediuk NV; Pokrovskiĭ AG; Baltina LA; Murinov IuI; Tolstikov GA
    Vopr Virusol; 1992; 37(5-6):235-8. PubMed ID: 1290221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon inhibits the replication of HIV-1, SIV, and SHIV chimeric viruses by distinct mechanisms.
    Korth MJ; Taylor MD; Katze MG
    Virology; 1998 Aug; 247(2):265-73. PubMed ID: 9705919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.